RESUMEN

Breast and gynecological cancers affect almost 900,000 women and therefore most health care providers will be involved at some point in the management of women with cancer. As the prognosis of all cancers is much more favorable when diagnosed in early stages, it is imperative that all health care providers are familiar not only with current screening guidelines for the average population, but also with the identification of high risk individuals who may benefit from more intense screening as well as available interventions to prevent disease or decrease risk. The purpose of this review article is to provide relevant information to physicians and other health care providers to aid in identifying patients that are classified as "high risk" for developing breast or a gynecologic cancer, outlining what interventions exist for adequate screening and risk reduction strategies, and to provide an update on current screening guidelines for individuals at average and high risk.

Asunto(s)

Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/prevención & control , Neoplasias Ováricas/diagnóstico , Neoplasias Ováricas/prevención & control , Neoplasias del Cuello Uterino/diagnóstico , Neoplasias del Cuello Uterino/prevención & control , Neoplasias de la Mama/genética , Detección Precoz del Cáncer/métodos , Femenino , Predisposición Genética a la Enfermedad/genética , Predisposición Genética a la Enfermedad/prevención & control , Terapia de Reemplazo de Hormonas/efectos adversos , Humanos , Factores de Riesgo , Fumar/efectos adversos , Fumar/genética , Neoplasias del Cuello Uterino/genética